The effect of the orientation of the non-recrystallized grains (non-DRX) and the LPSO phase on plasticity in extruded Mg97Y2Zn1 alloy with a bimodal grain structure have been studied in-situ using the combination of synchrotron diffraction and acoustic emission techniques during compression tests. The adaptive sequential k-means (ASK) procedure was applied to analyze the acoustic emission signal. This method can successful separate the signal for each possible deformation systems. Combining both techniques the deformation mechanisms that take place during the compression tests under different loading directions have been distinguish. Independently of the loading direction, the beginning of the macroscopic plasticity is always controlled by the activation of basal slip system in the DRX grains. However, highly oriented non-DRX grains and LPSO phase have a strong influence over the compressive deformation of the MgY2Zn1 alloy. The basal planes in the non-DRX grains were oriented parallel to the extrusion direction (ED). Thus, the activation of the extension twinning was found to be significant only in the ED mode. In the other two loading cases, TD and 45, the activation of non-basal slip systems has been detected. On the other hand, the reinforcing effect of the 1012 1011 2 elongated LPSO phase is the most effective, if the loading axis is aligned with the fiber direction (extrusion direction) since the load transfer mechanism is more effective. In this loading case, the LPSO can be plastically deformed due to kinking. This deformation mode has been isolated by the ASK procedure and characterized by in-situ scanning electron microscopy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.